NSC |
Compound |
Enrichment |
Correlation |
NSC 707465 |
2-Butenoic acid, 4-[[4,5-dichloro-2-[[[[2-(1-pyrrolidinyl)cyclohexyl] (methyl)amino]carbonyl]methyl]phenyl]amino]-4-oxo-, methyl ester, (1S,2S)- |
0.0278435641331422 |
0.052538053 |
NSC 709100 |
Null |
0.0278435641331422 |
0.1745396 |
NSC 710779 |
Null |
0.0278435641331422 |
0.31666335 |
NSC 728040 |
2-[4-(methoxy)phenyltio]-3-phenyl-5,7-diamino quinoxaline |
0.0278435641331424 |
0.23296101 |
NSC 736079 |
4-[(Z)-2-(5-nitro-thiophen-2-yl)ethenyl]-6-pyrrolidin-1-yl-1 ,3,5-triazin-2-ylamine |
0.0278435641331424 |
0.35418971 |
NSC 736988 |
6-(3-Aminopropyl)-5,6-dihydro-9-methoxy-5,11-dioxo-11H-inden o[1,2-c]isoquinoline Hydrochloride |
0.0278435641331424 |
0.432328 |
NSC 737671 |
6-(3-Aminopropyl)-5,6-dihbydro-3-nitro-5,11-dioxo-9-phenyl-1 1H[1,2-c]isoquinoline Hydrochloride |
0.0278435641331424 |
0.25375265 |
NSC 743244 |
Null |
0.0278435641331424 |
0.18474774 |
NSC 745813 |
Null |
0.0278435641331424 |
0.21280514 |
NSC 746513 |
5-Triazol-2-yl-methyl-2-[2?,(2??-chlorophenyl)-thiazolidin-4?-one-3?-yl]-1,3,4-oxadiazole |
0.0278435641331424 |
0.1976963 |